References
1. Sumit Gupta & Sheila Weitzman (2010) Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy, Expert Review of Clinical Immunology, 6:1, 137-154, DOI: 10.1586/eci.09.58
2. Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X: Adult haemophagocytic syndrome. Lancet. 2014, 383:1503-1516. 10.1016/S0140-6736(13)61048-X
3. Aghamohammad S, Badmasti F, Solgi H, Aminzadeh Z, Khodabandelo Z, Shahcheraghi F: First Report of Extended-Spectrum Betalactamase-Producing Klebsiella pneumoniae Among Fecal Carriage in Iran: High Diversity of Clonal Relatedness and Virulence Factor Profiles. Microb Drug Resist. 2020, 26:261-269. 10.1089/mdr.2018.0181
4. Luan, Y., Sun, Y., Duan, S., Zhao, P., & Bao, Z. (2018). Pathogenic bacterial profile and drug resistance analysis of community-acquired pneumonia in older outpatients with fever. Journal of International Medical Research, 030006051878691. doi:10.1177/0300060518786915
5. Venkataraman R, Divatia JV, Ramakrishnan N, Chawla R, Amin P, Gopal P, Chaudhry D, Zirpe K, Abraham B: Multicenter Observational Study to Evaluate Epidemiology and Resistance Patterns of Common Intensive Care Unit-infections. Indian J Crit Care Med. 2018, 22:20-26. 10.4103/ijccm.IJCCM_394_17
6. Ronald Jaffe, The Histiocytoses, Clinics in Laboratory Medicine, Volume 19, Issue 1, 1999, Pages 135-156, ISSN 0272-2712, https://doi.org/10.1016/S0272-2712(18)30132-X.
7. Greinacher A, Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood. 2016 Dec 29;128(26):3032-3042. doi: 10.1182/blood-2016-09-693655. Epub 2016 Nov 9. PMID: 28034871.
8. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL: How I treat hemophagocytic lymphohistiocytosis. Blood. 2011, 118:4041-4052. 10.1182/blood-2011-03-278127
9. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-131. 10.1002/pbc.21039
10. Hayden A, Park S, Giustini D, Lee AY, Chen LY: Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review. Blood Rev. 2016, 30:411-420. 10.1016/j.blre.2016.05.001
11. Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, Sako M, Hibi S: Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001, 19:2665-2673. 10.1200/JCO.2001.19.10.2665
12. Thomas D, Shah N, Patel H, Pandya T, Gauchan D, Maroules M: Hemophagocytic Lymphohistiocytosis: A Series of Five Clinical Cases in Adult Patients at a Single Institution with a Review of the Literature. N Am J Med Sci. 2015, 7:415-420. 10.4103/1947-2714.166225
13. Arca M, Fardet L, Galicier L, Riviere S, Marzac C, Aumont C, Lambotte O, Coppo P: Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol. 2015, 168:63-68. 10.1111/bjh.13102
14. Zoller EE, Lykens JE, Terrell CE, Aliberti J, Filipovich AH, Henson PM, Jordan MB: Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med. 2011, 208:1203-1214.10.1084/jem.20102538
15. Long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.ClinicalTrials.gov/NCT02069899